Article
Genomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancer.
The oncologist - 6 Feb 2025
Pappas Leontios, Quintanilha Julia C F, Huang Richard S P, Parikh Aparna R
Abstract excerpt
BACKGROUND: The molecular characterization of early-stage (1-3) colorectal cancer (CRC) remains incomplete, as opposed to metastatic disease, where comprehensive genomic profiling (CGP) is routinely performed. This study aimed to characterize the genomics of stages 1-3 versus IV CRC, and the genomics of patients recurring within 1 year of diagnosis. PATIENTS AND METHODS: Patients from a de-identified CRC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
